Beyond borders: global biotechnology report 2012
Holistic open learning networks
The underlying inefficiency and redundancy of drug development have become particularly incongruous in the current financing climate — an extravagance the industry can no longer afford.
Holistic open learning networks (HOLNets) could make R&D shades more efficient by harnessing the power of big data to develop real-time insights.
Even as biotech adjusts to its new normal, health care is moving to an outcomes-based ecosystem characterized by new incentives, new technologies and big data.
HOLNets could reinvent R&D by pooling data, creating standards and engaging regulators and patients.
Now, more than ever, this approach is feasible because it is in the self interest of the entities that would need to be part of it.